WASHINGTON (AP) — Federal officials have approved another generic version of the abortion pill mifepristone , a regulatory formality that quickly triggered pushback from anti-abortion groups and politicians aligned with the Trump administration.

Drugmaker Evita Solutions announced on its website that the Food and Drug Administration signed off on its low-cost form of the pill , which is approved to end pregnancies through 10 weeks. ×

This page requires Javascript.

Javascript is required for you to be able to read premium content. Please enable it in your browser settings. kAm$EF56?ED 7@C {:76 p4E:@?[ H9:49 @AA@D6D 23@CE:@?[ :? 2 DE2E6>6?E %9FCD52J 42==65 E96 2AAC@G2= “2 DE2:? @? E96 %CF>A AC6D:56?4J 2?5 2?@E96C D:8? E92E E96 566A DE2E6 2E E96 usp >FDE 8@]”k^Am kAm#6AF3=:42

See Full Page